Skip to main content
. 2021 Mar 18;45(7):2015–2026. doi: 10.1007/s00268-021-06057-9

Table 2.

Respiratory, cytokine and quality of life parameters at admission in both groups

Characteristic Physiotherapy (n = 42) Yoga therapy (n = 38) p value
Pulmonary function tests:
VT (ltrs) 0.37 ± 0.12 0.41 ± 0.2 0.24
FVC 35.3 ± 9.10 38.1 ± 8.90 0.16
FEV1 35.8 ± 10.63 38.7 ± 8.20 0.16
PEF 33.9 ± 9.80 34.4 ± 8.45 0.82
FEV1/FVC 106.5 ± 17.20 107.1 ± 12.20 0.85
Respiratory muscle endurance: MVV (ltrs) 25.6 ± 8.5 27.1 ± 7.22 0.40
Chest wall expansion (cm):
Axillary cirtometry 3.0 ± 0.32 2.9 ± 0.39 0.15
Thoracic cirtometry 3.8 ± 0.28 3.7 ± 0.41 0.14
Respiratory muscle strength: Diaphragm motion at normal breathing (mm)
Right 15.4 ± 4.14 15.4 ± 4.81 0.99
Left 20.5 ± 5.89 21.0 ± 6.55 0.73
Diaphragm motion at deep breathing (mm)
Right 21.7 ± 6.15 21.9 ± 5.53 0.86
Left 27.3 ± 6.20 30.1 ± 9.7 0.12
Diaphragm thickness at normal breathing (mm)
Right 1.77 ± 0.52 1.82 ± 0.45 0.65
Left 1.62 ± 0.44 1.62 ± 0.39 0.94
Diaphragm thickness at deep breathing (mm)
Right 2.08 ± 0.6 2.1 ± 0.56 0.88
Left 1.93 ± 0.64 1.98 ± 0.62 0.69
Cytokines
IL-2 633.0 ± 1360.98 670.5 ± 1209.8 0.48
IL-4 1065.8 ± 5670.7 315.8 ± 351.20 0.41
IL-8 673.5 ± 1295.10 1833.2 ± 4317.73 0.12
IL-10 100.91 ± 112.88 99.2 ± 103.78 0.93
IL-12 501.4 ± 814.36 360.3 ± 659.56 0.73
TNF-α 201.3 ± 433.04 300.4 ± 589.90 0.54
IFN-γ 288.9 ± 396.27 323.8 ± 432.43 0.60
WHO QoL:
Physical 55.6 ± 10.72 49.4 ± 16.91 0.05
Psychological 64.3 ± 13.57 61.9 ± 17.65 0.51
Social relations 60.2 ± 14.67 60.8 ± 20.96 0.88
Environmental 51.0 ± 13.80 51.1 ± 15.70 0.98

*VT Tidal Volume, FVC Forced Vital Capacity, FEV1 Forced Expiratory Volume in one Second, PEF Peak Expiratory Force, MVV Maximum voluntary ventilation, IL Interleukin, TNF-α Tumor Necrosis Factor-a, IFN-γ Interferon-γ, WHO QoL World Health Organization Quality of Life